Health-related content. Aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before making decisions. .

Cuspart: Blood Sugar

Cuspart: Blood Sugar

By Mustafa Tolga DALBUDAK

Cuspart is a medical tracking app for diabetes management that uses a local-first, one-time payment model on iOS and Android.

The App DNA

What makes this app unique?

Users hire Cuspart to maintain clinical health records without the privacy risks or recurring costs associated with cloud-synced medical trackers.

For Individuals managing diabetes or glucose levels who require a private, offline-capable tool for health tracking and clinical reporting.

What does it look like?

Key features

Offline Data Loggingedge

Log glucose, insulin, and vitals without an active internet connection

Professional PDF/CSV Reportingstandard

Generate and share health history reports for physician review

Local Data Privacyedge

Store all health data locally on the device rather than on external servers

How much does it cost?

freemiumFree tier with core tracking featuresPro tier via one-time payment for full offline functionality

Freemium model utilizing a one-time purchase to unlock offline capabilities, avoiding recurring subscription fatigue.

Velocity

Maintenance developmentUX improvementsperformanceopaqueShow more...

Development momentum has slowed significantly, with only 4 releases identified over the last 15 months. The latest release provided no descriptive notes, while previous updates focused on minor UI refinements and performance. There is no evidence of a live-ops strategy or a consistent feature-delivery pipeline. The current cadence of roughly 0.06 releases per week places the app firmly in the maintenance tier.

See all version history

Who built it?

Mustafa Tolga DALBUDAK

13+ apps tracked · Medical

Cuspart: AcilCuspart: AcilRehber: Antik Kentler, MüzelerRehber: Antik Kentler, MüzelerCuspart: Dash CamCuspart: Dash CamCuspart: GPSCuspart: GPSCuspart: EarthquakeCuspart: EarthquakeCuspart: Ez Tabuu+Cuspart: Ez Tabuu+Cuspart: Soru Cevap+Cuspart: Soru Cevap+Cuspart: Altímetro+Cuspart: Altímetro+Percent Calculator AppPercent Calculator AppCuspart: CalculatorCuspart: CalculatorCuspart: Soru CevapCuspart: Soru CevapCuspart: Call BlockerCuspart: Call Blocker
Explore the full publisher profile

User Sentiment

What do users think recently?

How are ratings & reviews evolving?

App Store
5.00 · 1
Google Play
0.00 · 0

Not enough recent reviews to extract reliable themes yet.

Read the full review analysis

Competition

Competitive landscape for Cuspart: Blood Sugar

How's the Medical market?

Cuspart maintains a niche position in the medical category by prioritizing local data storage over the cloud-sync features standard in the top 10 health trackers.

Read the market outlook

The rivals identified

Shotsy GLP-1 Tracker
Shotsy GLP-1 Trackeractive nemesis

By Shotsy

Shotsy directly competes for the same chronic condition management audience by focusing on medication adherence and glucose trends, mirroring Cuspart's goal of simplifying complex health data.

  • Offers sophisticated medication level estimation which provides deeper clinical context than simple manual logging tools
  • Maintains a high-velocity release cadence with five updates in six months, ensuring superior platform stability
  • Leverages massive social proof and user volume to dominate search visibility within the health category
Cuspart: Blood Sugar vs Shotsy GLP-1 Tracker

Unlock the head-to-head verdict: where this rival wins, and where it loses.

Access the full report for free

The Analyst's Read

Key takeaways for Cuspart: Blood Sugar

Where is it heading?

The medical tracking market is consolidating around apps that offer automated wearable integration, leaving manual-entry tools like Cuspart increasingly exposed. The PM must transition from a manual-logging utility to an integrated health hub to prevent user migration to hardware-connected competitors.

  • The recent Android launch expands the addressable market, allowing the app to capture users outside the iOS-only segment.
  • The total lack of Android ratings post-launch suggests low discovery or high friction in the initial user funnel.

The SWOT

Core Strengths
  • Local-only data architecture eliminates cloud-based security risks
  • One-time purchase model removes recurring subscription friction
Critical Frictions 2 weaknesses inside
Growth Levers
  • Develop Apple Health and Google Fit integration to reduce manual entry
  • Target privacy-conscious users migrating from cloud-heavy competitors
Market Threats 2 threats identified

Next best moves

1 Invest · 1 Pivot

Ship Apple Health and Google Fit integration because manual logging is the primary friction point → increase daily retention

+ 1 more prioritized move

The counter-intuitive read

The privacy-first local storage is not just a…

Read the full take

Feature gaps

Automated CGM integration (available in GotCGM but missing here) +2

Since the last report: The competitive outlook shifted to address specific high-velocity rivals and the failure of the Android launch to generate user feedback.

Bottom line

Cuspart secures a privacy-focused niche through its local-first architecture, but the lack of automated CGM integration limits its long-term retention against hardware-connected rivals, so the PM must prioritize ecosystem data syncing to remain competitive.

Unlock 2 critical frictions, 2 market threats, 1 more prioritized move and the analyst’s take.

Access the full report for free

Report last updated

Disclosure: Independent intel to help mobile builders succeed.

AI-powered analysis with automated quality gates, built from publicly available sources. Marlvel.ai is not affiliated with, endorsed by, or sponsored by Cuspart: Blood Sugar, its developer, the app publisher, Apple, or Google Play. All trademarks, logos, and screenshots referenced remain the property of their respective owners.

What's new

The competitive outlook shifted to address specific high-velocity rivals and the failure of the Android launch to generate user feedback.

shifted

Competitive Threat Landscape

added

Android Platform Weakness

B2B Distribution Barrier

added

Android Onboarding Audit

Cite this report

Marlvel.ai. “Cuspart: Blood Sugar Intelligence Report.” Updated May 19, 2026. https://marlvel.ai/apps/cuspart-blood-sugar

Agent Markdown (.md)See methodologyContact support

Data licensed under CC-BY-NC 4.0